Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
1996-05-09
2001-01-09
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S173000
Reexamination Certificate
active
06172056
ABSTRACT:
BACKGROUND OF THE INVENTION
The invention relates to novel pharamaceutical preparations for prophylaxis and therapy of radical-mediated cell damage.
From professional and patent literature it is known that reactive oxygen species (ROSs), free oxygen radicals and other radial forms play an important role in the occurrence of many kinds of cell damage, such as ischemic and traumatic organ injuries, and inflammatory and toxic processes.
A negative effect of ROSs, free oxygen radicals and other forms of radicals can also be found in brain and spinal column injuries, shock states, stroke, muscular dystrophy, emphysemas, adult respiratory distress syndrome (ARDS), asthma, aging processes, in tissue damage after myocardial infarction, damage from toxic processes and radiation, burns, and transplant-dictated immune reactions. Among other factors, lipid peroxidation and the oxidation of low-density lipoprotein (LDL) cholesterol, combined with irreversible membrane and endothelial damage are the starting point for such radical-mediated cell damage.
It is also known that lipophilic substances, such as lipophilic steroids, with “radical-trapping” properties can be suitable for prophylaxis and therapy of radical-mediated cell damage.
Unlike the known low-molecular phenolic antioxidants, these lipophilic steroids are transported with a certain selectivity into the region of the cell membrane or endothilium, where they can develop their efficacy.
The therapeutic utility is determined by the action spectrum of the respective substance.
International Patents WO 87/01716 and WO 91/11453, European Patents EP 0 389 368, EP 0 389 369, and EP 0 389 370, and French Patent FR 2 640 977, for instance, describe steroids with “radical-trapping” properties.
WO 87/01716, WO 91/11453 and EP 0 389 368/. . . 369/ . . . 370 describe steroids describe steroids which contain an amino group, which can be substituted or part of a heterocyclic ring system, this amino group being bonded to the terminal carbon atom of a side chain at the C
17
position of the steroid.
In FR 2 640 977, a structural type is shown that has a substituted phenyl ring in the &bgr; position on the C
11
atom.
It is shown in J. Phys. Org. Chem. 3 (1990), 309-315 that estrogens, and especially catechol estrogens, can act as radical catchers. Estradiol, estrone, estriol and 2-hydroxyestradiol inhibit peroxidation in vitro and in vivo.
REFERENCES:
patent: 3436411 (1969-04-01), Stein et al.
patent: 4897389 (1990-01-01), Aroonsakul
patent: 5405944 (1995-04-01), Suzuki
patent: 5554601 (1996-09-01), Simpkins et al.
patent: 0389370 (1990-03-01), None
patent: 0389368 (1990-09-01), None
patent: 2640977 (1988-12-01), None
patent: WO87/01706 (1987-03-01), None
patent: WO91/11453 (1991-08-01), None
WPIDS AN 93-110917, Ishida et al., 1993.
WPNDS AN 96-041521, Ishida et al., 1992.
CAS119:109303, Mooradian, J. Ster. Biochem. Mol. Biol., 1993.
CA121:179977, Jun. 1, 1994.
CA 108: 198542, Gyhing et al, J Ster. Bioch., 1988.
CA 105:219024, Barth et al, Arch. Int. Pharmacodyn. Ther, 1986.
A. Mooradian “Antioxidants Properties of Steroids”, J. Steroid. Biochem. Molec. Biol., vol. 45, No. 6, pp. 509-511 (1993).
H. Esterbauer, et al “Effect of Peroxidative Conditions of Human Plasma Low-Density Lipoproteins”, Eicosanoids, Lipid Peroxidation and Cancer, S.K. Nigam, D.C. H. McBrien, eds., Springer-Veriag, pp. 203-213.
J. Phys. Org. Chem. Inhibition of Peroxidatons of Lipids and Membranes by Estro_Gens. Komuro, et al., vol. 3, 309-315, 1990.
Eicosanoids, Lipid Peroxidation and Cancer; Nigam, et al., 1988, pp. 203-213.
Droescher Peter
Kaufmann G{umlaut over (u)}nter
Menzenbach Bernd
Oettel Michael
Ponsold Kurt
Cook Rebecca
JENAPHARM GmbH & Co. KG
Striker Michael J.
LandOfFree
Pharmaceutical compositions and method for prophylaxis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and method for prophylaxis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and method for prophylaxis and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2553754